NO20080797L - Bicykliske heterocykler som HIV Integrase inhibitorer - Google Patents

Bicykliske heterocykler som HIV Integrase inhibitorer

Info

Publication number
NO20080797L
NO20080797L NO20080797A NO20080797A NO20080797L NO 20080797 L NO20080797 L NO 20080797L NO 20080797 A NO20080797 A NO 20080797A NO 20080797 A NO20080797 A NO 20080797A NO 20080797 L NO20080797 L NO 20080797L
Authority
NO
Norway
Prior art keywords
hiv integrase
hiv
integrase inhibitors
bicyclic heterocycles
inhibitors
Prior art date
Application number
NO20080797A
Other languages
English (en)
Inventor
Jacques Banville
Roger Remillard
Serge Plamondon
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20080797L publication Critical patent/NO20080797L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Oppfinnelsen omfatter en serie sykliske bisykliske, heterosykliske forbindelser med formel I som er inhibitorer av HIV-integrase og forhindrer viral integrering i humant DNA. Denne virkningen gjør forbindelsene anvendelige for behandling av HIV-infeksjon og AIDS. Oppfinnelsen omfatter også farmasøytiske preparater og fremgangsmåter for behandling av de infisert med HIV. (I)
NO20080797A 2005-08-31 2008-02-14 Bicykliske heterocykler som HIV Integrase inhibitorer NO20080797L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71308005P 2005-08-31 2005-08-31
PCT/US2006/033832 WO2007027754A1 (en) 2005-08-31 2006-08-30 Bicyclic heterocycles as hiv integrase inhibitors

Publications (1)

Publication Number Publication Date
NO20080797L true NO20080797L (no) 2008-05-16

Family

ID=37671032

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080797A NO20080797L (no) 2005-08-31 2008-02-14 Bicykliske heterocykler som HIV Integrase inhibitorer

Country Status (6)

Country Link
US (1) US7494984B2 (no)
EP (1) EP1919921B1 (no)
JP (1) JP2009508817A (no)
CN (1) CN101253177B (no)
NO (1) NO20080797L (no)
WO (1) WO2007027754A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0609719B8 (pt) * 2005-03-23 2021-05-25 Hoffmann La Roche derivados de acetilenil-pirazol-pirimidina como antagonistas de mgbur2
US7763630B2 (en) * 2007-06-06 2010-07-27 Bristol-Myers Squibb Company HIV integrase inhibitors
US8129398B2 (en) * 2008-03-19 2012-03-06 Bristol-Myers Squibb Company HIV integrase inhibitors
EA201170537A1 (ru) * 2008-10-06 2011-12-30 Мерк Шарп Энд Домэ Корп. Ингибиторы вич-интегразы
US8143244B2 (en) * 2009-02-26 2012-03-27 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
US8383639B2 (en) 2009-10-15 2013-02-26 Bristol-Myers Squibb Company HIV integrase inhibitors
WO2014099586A1 (en) 2012-12-17 2014-06-26 Merck Sharp & Dohme Corp. 4-pyridinonetriazine derivatives as hiv integrase inhibitors
US9493479B2 (en) 2013-04-16 2016-11-15 Merck Sharp & Dohme Corp. Substituted pyrido[1,2-a]pyrazines as HIV integrase inhibitors
ME02977B (me) 2013-05-17 2018-10-20 Merck Sharp & Dohme Fuzionisana triciklicna heterociklicna jedinjenja као inhibiтori hiv integraze
US9951079B2 (en) 2013-06-13 2018-04-24 Merck Sharp & Dohme Corp. Fused tricyclic heterocyclic compounds as HIV integrase inhibitors
EA030695B1 (ru) 2013-09-27 2018-09-28 Мерк Шарп И Доум Корп. Замещенные производные хинолизина, которые можно использовать как ингибиторы интегразы вич
WO2016187788A1 (en) 2015-05-25 2016-12-01 Merck Sharp & Dohme Corp. Fused tricyclic heterocyclic compounds useful for treating hiv infection
NZ739853A (en) 2015-09-10 2018-11-30 Dow Agrosciences Llc Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
WO2017087257A1 (en) 2015-11-17 2017-05-26 Merck Sharp & Dohme Corp. Amido-substituted pyridotriazine derivatives useful as hiv integrase inhibitors
US10544155B2 (en) 2015-12-15 2020-01-28 Merck Sharp & Dohme Corp. Spirocyclic quinolizine derivatives useful as HIV integrase inhibitors
WO2017113288A1 (en) 2015-12-31 2017-07-06 Merck Sharp & Dohme Corp. Fused tricyclic heterocyclic compounds as hiv integrase inhibitors
JOP20190130A1 (ar) 2016-12-02 2019-06-02 Merck Sharp & Dohme مركبات حلقية غير متجانسة رباعية الحلقات مفيدة كمثبطات إنزيم مدمج لفيروس نقص المناعة البشرية (hiv)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7414045B2 (en) * 2002-12-27 2008-08-19 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Substituted pyrimido[1,2-a]azepines useful as HIV integrase inhibitors
JP2004244320A (ja) 2003-02-10 2004-09-02 Shionogi & Co Ltd 含窒素複素環抗ウイルス剤
AR046938A1 (es) 2003-12-12 2006-01-04 Merck & Co Inc Procedimiento para preparar hexahidropirimido[1,2-a]azepin-2-carboxilatos y compuetos similares
TW200526635A (en) 2003-12-22 2005-08-16 Shionogi & Co Hydroxypyrimidinone derivative having HIV integrase inhibitory activity
US7273859B2 (en) 2004-05-12 2007-09-25 Bristol-Myers Squibb Company HIV integrase inhibitors: cyclic pyrimidinone compounds
US7115601B2 (en) 2004-05-18 2006-10-03 Bristol-Myers Squibb Company HIV integrase inhibitors
US7176196B2 (en) 2004-05-28 2007-02-13 Bristol-Myers Squibb Company Bicyclic heterocycles as HIV integrase inhibitors
US7173022B2 (en) 2004-05-28 2007-02-06 Bristol-Myers Squibb Company Bicyclic heterocycles as HIV integrase inhibitors
US7192948B2 (en) 2004-05-28 2007-03-20 Bristol-Myers Squibb Company Bicyclic heterocycles as HIV integrase inhibitors
AU2006228278C1 (en) 2005-03-31 2011-06-23 Msd Italia S.R.L. HIV integrase inhibitors

Also Published As

Publication number Publication date
CN101253177A (zh) 2008-08-27
CN101253177B (zh) 2012-09-19
US7494984B2 (en) 2009-02-24
WO2007027754A1 (en) 2007-03-08
JP2009508817A (ja) 2009-03-05
EP1919921B1 (en) 2012-06-27
US20070049606A1 (en) 2007-03-01
EP1919921A1 (en) 2008-05-14

Similar Documents

Publication Publication Date Title
NO20080797L (no) Bicykliske heterocykler som HIV Integrase inhibitorer
NO20065879L (no) Bisykliske heterosykler som HIV-integraseinhibitorer
NO20082135L (no) HIV integrase inhibitorer
NO20081935L (no) HIV-integraseinhibitorer
WO2008002959A3 (en) Hiv integrase inhibitors
NO20065443L (no) HIV-Integraseinhibitorer: Sykliske pyrimidinonforbindelser
WO2007059125A3 (en) Hiv integrase inhibitors
MX2010009995A (es) Heterociclos puenteados como inhibidores de la integrasa del virus de inmunodeficiencia humana.
WO2005115398A3 (en) Hiv integrase inhibitors
NO20070137L (no) Heterocykliske antivirale forbindelser
NO20060665L (no) N-substituerte pyrazolyl-amidyl-benzimidazolyl C-kit inhibitorer
DE602006020152D1 (de) Arylalkyl- und heteroarylalkyl-derivate von cyclosporin a bei der behandlung und vorbeugung einer virusinfektion
NO20062561L (no) Kinoliner nyttige for behandling av kardiovaskulaere sykdommer
WO2004096128A3 (en) Hiv integrase inhibitors
EA201001273A1 (ru) Ингибиторы вируса гепатита с
DE602007013252D1 (de) Azyklische amininhibitoren von nukleosidphosphorylasen und hydrolasen
MX2010005292A (es) Inhibidores de la replicacion del virus de la inmunodeficiencia humana.
TW200635918A (en) Pharmaceutical compounds
GB0612423D0 (en) Therapeutic agents
NO20084645L (no) Cyklopropyl kondenserte indolobenzazepin HCV NS5B inhibitorer
MX2012002542A (es) Compuestos y composiciones como inhibidores de cinasa de proteina.
EA201391670A1 (ru) 1,3-оксазины в качестве ингибиторов bace1 и/или bace2
NO20063958L (no) HIV integrase inhibitorer
NO20063449L (no) Substituerte heterocykler og deres anvendelse
NO20060664L (no) N-substituerte benzimidazolyl C-kit inhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application